Biochemistry, Tissue factor, Factor VII, Molecular biology and Factor X are his primary areas of study. His work deals with themes such as Endothelial stem cell, Cell biology and Immunology, Fibrin, which intersect with Tissue factor. His Factor VII study integrates concerns from other disciplines, such as Serine, Recombinant factor VIIa, Hemostasis, Clotting factor and Isoantibodies.
His Molecular biology research incorporates themes from Protease, Endogeny, Proinflammatory cytokine, Interleukin and Transcription. His study looks at the intersection of Factor X and topics like Factor IX with Kallikrein, High-molecular-weight kininogen and Factor XI. His Tissue-factor-pathway inhibitor 2 research integrates issues from Extracellular matrix and Tissue factor pathway inhibitor.
His scientific interests lie mostly in Tissue factor, Biochemistry, Molecular biology, Factor VII and Factor X. His Tissue factor research is multidisciplinary, incorporating elements of Immunology and Pathology. His studies deal with areas such as Cell culture, In vitro, DNA, A-DNA and Protein C as well as Molecular biology.
His Factor VII research is multidisciplinary, incorporating elements of Antithrombin, Stereochemistry, Recombinant factor VIIa, Clotting factor and Binding site. His Factor X research includes elements of Factor IX and Peptide. The Tissue-factor-pathway inhibitor 2 study which covers Cell biology that intersects with Endothelial stem cell.
Walter Kisiel focuses on Tissue factor, Cancer, Cancer research, Immunology and Molecular biology. His biological study focuses on Tissue factor pathway inhibitor. The various areas that Walter Kisiel examines in his Tissue factor pathway inhibitor study include Factor IX and Factor X.
His Cancer study also includes fields such as
His primary areas of investigation include Cancer, Tissue factor, Cancer cell, Molecular biology and Tissue factor pathway inhibitor. His Cancer research incorporates elements of Cancer research, Angiogenesis and Immunology. His Tissue factor research includes themes of Intron and Exon.
His work deals with themes such as Colorectal cancer and Pathology, which intersect with Cancer cell. His research integrates issues of Serine, DNA methylation, Alternative splicing, Promoter and RNA splicing in his study of Molecular biology. His research in Tissue factor pathway inhibitor intersects with topics in Plasmin, Cancer procoagulant, Factor X, Protein C and Protein Z.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The coagulation cascade: initiation, maintenance, and regulation
Earl W. Davie;Kazuo Fujikawa;Walter Kisiel.
Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model
Marion A. Hofmann;Evanthia Lalla;Yan Lu;Michelle Ryu Gleason.
Journal of Clinical Investigation (2001)
Human Plasma Protein C: ISOLATION, CHARACTERIZATION, AND MECHANISM OF ACTIVATION BY α-THROMBIN
Journal of Clinical Investigation (1979)
Anticoagulant properties of bovine plasma protein C following activation by thrombin.
Walter Kisiel;William M. Canfield;Lowell H. Ericsson;Earl W. Davie.
Characterization of a cDNA coding for human factor VII
Steven P. Leytus;Dominic W. Chung;Walter Kisiel;Kotoku Kurachi.
Proceedings of the National Academy of Sciences of the United States of America (1984)
Use of human factor VIIa in the treatment of two hemophilia A patients with high-titer inhibitors.
Ulla Hedner;Walter Kisiel.
Journal of Clinical Investigation (1983)
Proteolytic activation of protein C from bovine plasma.
Walter Kisiel;Lowell H. Ericsson;Earl W. Davie.
Tissue factor pathway inhibitor-2 is a novel inhibitor of matrix metalloproteinases with implications for atherosclerosis
Michael P. Herman;Galina K. Sukhova;Walter Kisiel;Don Foster.
Journal of Clinical Investigation (2001)
An endothelial cell-dependent pathway of coagulation
David Stern;Peter Nawroth;Dean Handley;Walter Kisiel.
Proceedings of the National Academy of Sciences of the United States of America (1985)
Factor X activating enzyme from Russell's viper venom: isolation and characterization.
Walter Kisiel;Mark A. Hermodson;Earl W. Davie.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: